rs373609902

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_004208.4(AIFM1):​c.72C>T​(p.Cys24Cys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000673 in 1,199,365 control chromosomes in the GnomAD database, including 2 homozygotes. There are 234 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00049 ( 0 hom., 14 hem., cov: 24)
Exomes 𝑓: 0.00069 ( 2 hom. 220 hem. )

Consequence

AIFM1
NM_004208.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 2.96

Publications

0 publications found
Variant links:
Genes affected
AIFM1 (HGNC:8768): (apoptosis inducing factor mitochondria associated 1) This gene encodes a flavoprotein essential for nuclear disassembly in apoptotic cells, and it is found in the mitochondrial intermembrane space in healthy cells. Induction of apoptosis results in the translocation of this protein to the nucleus where it affects chromosome condensation and fragmentation. In addition, this gene product induces mitochondria to release the apoptogenic proteins cytochrome c and caspase-9. Mutations in this gene cause combined oxidative phosphorylation deficiency 6 (COXPD6), a severe mitochondrial encephalomyopathy, as well as Cowchock syndrome, also known as X-linked recessive Charcot-Marie-Tooth disease-4 (CMTX-4), a disorder resulting in neuropathy, and axonal and motor-sensory defects with deafness and cognitive disability. Alternative splicing results in multiple transcript variants. A related pseudogene has been identified on chromosome 10. [provided by RefSeq, Aug 2015]
RAB33A (HGNC:9773): (RAB33A, member RAS oncogene family) The protein encoded by this gene belongs to the small GTPase superfamily, Rab family. It is GTP-binding protein and may be involved in vesicle transport. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.27).
BP6
Variant X-130165585-G-A is Benign according to our data. Variant chrX-130165585-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 367894.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.95 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000489 (55/112579) while in subpopulation NFE AF = 0.000921 (49/53212). AF 95% confidence interval is 0.000715. There are 0 homozygotes in GnomAd4. There are 14 alleles in the male GnomAd4 subpopulation. Median coverage is 24. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 14 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AIFM1NM_004208.4 linkc.72C>T p.Cys24Cys synonymous_variant Exon 1 of 16 ENST00000287295.8 NP_004199.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AIFM1ENST00000287295.8 linkc.72C>T p.Cys24Cys synonymous_variant Exon 1 of 16 1 NM_004208.4 ENSP00000287295.3 O95831-1
AIFM1ENST00000675092.1 linkc.72C>T p.Cys24Cys synonymous_variant Exon 1 of 16 ENSP00000501772.1 A0A6Q8PFE1

Frequencies

GnomAD3 genomes
AF:
0.000489
AC:
55
AN:
112526
Hom.:
0
Cov.:
24
show subpopulations
Gnomad AFR
AF:
0.0000968
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000324
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000921
Gnomad OTH
AF:
0.000660
GnomAD2 exomes
AF:
0.000301
AC:
47
AN:
156137
AF XY:
0.000325
show subpopulations
Gnomad AFR exome
AF:
0.000180
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000448
Gnomad NFE exome
AF:
0.000560
Gnomad OTH exome
AF:
0.000501
GnomAD4 exome
AF:
0.000692
AC:
752
AN:
1086786
Hom.:
2
Cov.:
30
AF XY:
0.000619
AC XY:
220
AN XY:
355588
show subpopulations
African (AFR)
AF:
0.000115
AC:
3
AN:
26155
American (AMR)
AF:
0.00
AC:
0
AN:
34110
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19147
East Asian (EAS)
AF:
0.00
AC:
0
AN:
29659
South Asian (SAS)
AF:
0.00
AC:
0
AN:
52441
European-Finnish (FIN)
AF:
0.000355
AC:
14
AN:
39480
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4122
European-Non Finnish (NFE)
AF:
0.000860
AC:
719
AN:
836054
Other (OTH)
AF:
0.000351
AC:
16
AN:
45618
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
32
63
95
126
158
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000489
AC:
55
AN:
112579
Hom.:
0
Cov.:
24
AF XY:
0.000403
AC XY:
14
AN XY:
34765
show subpopulations
African (AFR)
AF:
0.0000966
AC:
3
AN:
31062
American (AMR)
AF:
0.00
AC:
0
AN:
10727
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2653
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3582
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2729
European-Finnish (FIN)
AF:
0.000324
AC:
2
AN:
6176
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
218
European-Non Finnish (NFE)
AF:
0.000921
AC:
49
AN:
53212
Other (OTH)
AF:
0.000652
AC:
1
AN:
1534
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.526
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000695
Hom.:
6
Bravo
AF:
0.000400

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:6
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jun 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

AIFM1: BP4, BP7, BS2 -

-
Clinical Genetics, Academic Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

May 04, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Charcot-Marie-Tooth disease Benign:1
-
Molecular Genetics Laboratory, London Health Sciences Centre
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Severe X-linked mitochondrial encephalomyopathy Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Combined oxidative phosphorylation deficiency;CN118851:Charcot-Marie-Tooth Neuropathy X Benign:1
Dec 12, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.27
CADD
Benign
13
DANN
Benign
0.95
PhyloP100
3.0
PromoterAI
-0.012
Neutral
RBP_binding_hub_radar
1.1
RBP_regulation_power_radar
2.8
Mutation Taster
=288/12
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs373609902; hg19: chrX-129299559; COSMIC: COSV99781009; API